PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#CYANOCOBALAMIN ×

UPDATED
Regulatorische Updates
10. Sept. 2026•1 Min. Lesezeit
FDA Lists Watson Labs' COBAVITE Injection (ANDA083064) as Discontinued
FDA records indicate that Watson Labs' injectable product COBAVITE, containing 1 mg/mL cyanocobalamin, is listed as discontinued under ANDA083064.
UPDATED
Regulatorische Updates
8. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA083022 for DODEX Injectable (Cyanocobalamin)
The FDA approved ANDA083022 for the DODEX injectable containing 1 mg/mL cyanocobalamin. The product is listed as discontinued.
1
UPDATED
Regulatorische Updates
2. Sept. 2026•1 Min. Lesezeit
FDA Approves Lupin’s CYANOCOBALAMIN Nasal Spray
The FDA granted approval for Lupin Pharmaceuticals' prescription nasal spray containing 0.5 mg per spray of CYANOCOBALAMIN under ANDA210629.
1